Medolab Science & Instruments Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 101.85%
- Profit Growth 118.69%
- Ebitda 70.53%
- Net Worth 16.75%
- Total Assets 34.04%
About Medolab Science & Instruments
Medolab Science & Instruments Private Limited (MSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 April 2013 and has a history of 11 years and nine months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kalyan Roy, Rupam Roy, and Dipa Roy serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909WB2013PTC192731
- Company No.
192731
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Medolab Science & Instruments?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalyan Roy  | Director | 29-Apr-2013 | Current |
| Rupam Roy | Director | 22-May-2023 | Current |
| Dipa Roy | Director | 29-Apr-2013 | Current |
Financial Performance of Medolab Science & Instruments.
Medolab Science & Instruments Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 101.85% increase. The company also saw a substantial improvement in profitability, with a 118.69% increase in profit. The company's net worth Soared by an impressive increase of 16.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medolab Science & Instruments?
In 2018, Medolab Science & Instruments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medolab Science & Instruments?
Medolab Science & Instruments has a workforce of 20 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medolab Science & Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medolab Science & Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
